COPD Linked to Three-Fold Greater Mortality Risk in Severe COVID-19 Patients – MD Magazine

The prevalence of comorbid chronic obstructive pulmonary disease (COPD) among patients hospitalized with coronavirus 2019 (COVID-19) is actually lower than its presence in the general population, according to a new observational cohort analysis.

In new data presented online during the American College of Chest Physicians (CHEST) 2020 Annual Meeting this week, investigators reported just 1 in 20 observed patients hospitalized with COVID-19 suffered from COPDversus significantly greater rates of cardiometabolic disease among the most severely ill patients.

Study authors Vikramaditya Samala Venkata, MD, and Gerard N. Kiernan, MD, both of Dartmouth-Hitchcock Medical Center, conducted a systematic electronic search-based assessment of COVID-19 clinical trials to define associations between baseline COPD and overall outcomes of hospitalized patients.

Current understanding of such associations is not yet comprehensive, but nonetheless troubling given the respiratory burden of the pandemic virus.

Although clinical data is limited, studies published so far raise concerns about an association between COPD and worse clinical outcomes in COVID-19, they wrote.

The systematic search included retrospective studies including original hospitalized COVID-19 patient data from any of 3 major databases. Venkata and Kiernan used pooled analysis with a random-effects model in order to interpret the associations between COPD and COVID-19.

Their analyses included 22 studies from 8 countries including 11,000-plus patients hospitalized with COVID-19. Mean patient age was 56 years old, with 58% reported as male.

Among all comorbidities, hypertension was the most prevalent in hospitalized patients, at 42%. Another 23% of patients had diabetes mellitus.

Investigators observed a COPD prevalence rate of just 5% (n = 437) in patients hospitalized with COVID-19. However, such patients faced a three-fold greater risk of mortality (odds ratio [OR], 3.23; 95% CI, 1.59 6.57; P <.05). They noted the global prevalence of COPD among patients >40 years old is approximately 9%.

One explanation may be precautions put in place by COPD patients and their friends, family, and neighbors to limit their risk of COVID-19 exposure, given fears of more severe disease risks for such patients.

While one would expect patients with prior lung disease to have greater mortality with COVID-19, it is curious to see that the prevalence of COPD was lower than the general population may reflect greater measures taken by COPD patients to avoid coronavirus exposure, investigators wrote.

Uniquely, Venkata and Kiernan also found that smoking was present in more than one-third (37%) of COVID-19 patientsyet patients who smoked faced only a 52% worsened risk of disease severity (OR, 1.52; 95% CI, 0.81 2.87; P = .20). Reasoning for a mixed association, they noted, is still unclear.

Investigators concluded that more randomized trials are necessary to understand relationships between COPD, smoking status, and hospitalized COVID-19 prognosis in patients.

This will alert clinicians to the worse prognosis of COVID-19 infection in patients with history of COPD and it will raise a question for future studies to look at the association between baseline COPD and COVID-19, they concluded.

The study, COVID-19 and COPD: Pooled Analysis of Observational Studies, was presented at CHEST 2020.

More here:

COPD Linked to Three-Fold Greater Mortality Risk in Severe COVID-19 Patients - MD Magazine

2 more local residents die of COVID-19 as new cases identified near The Villages – Villages-News

Two more local residents have lost their battles with the COVID-19 virus as cases continue to be identified just outside the confines of The Villages.

One of the latest fatalities was from Sumter County and the other was a resident of Marion County. They were identified Monday by the Florida Department of Health as:

No new cases of COVID-19 were reported in The Villages on Monday. In fact, three cases that had been attributed to mega-retirement community were removed from the overall list, bringing the total (Sumter, Lake and Marion counties) to 764. But 17 new cases were reported in communities just outside the confines of Floridas Friendliest Hometown. Those include:

Sumter County is now reporting 2,754 cases a decrease of two from Sunday to Monday among 1,562 men, 1,171 women, 10 non-residents and 11 people listed as unknown. A total of 206 cases have been reported in long-term care centers and 739 in correctional facilities. There have been 80 deaths and 270 people treated in area hospitals.

The Villages continues to pace Sumter County with 718 cases. Besides those mentioned above in Wildwood, others have been identified in Coleman (656), Bushnell (323, 140 of which are at the Sumter Correctional Institution among 103 inmates and 37 staff members), Oxford (139), Webster (100), Lake Panasoffkee (85), Center Hill (55), Sumterville (47) and the Lady Lake portion of the county (42). The federal prison in Coleman also is reporting 155 cases among 51 inmates and 104 staff members.

Below is a breakdown of other COVID-19 activity in the local area:

TRI-COUNTY AREA

LAKE COUNTY

MARION COUNTY

All told, Florida is reporting 756,727 COVID-19 cases an increase of 1,707 from Sunday to Monday. Of those, 747,183 are residents. A total of 49,401 cases have been reported in long-term care centers and 23,682 in correctional facilities. Across the state, there have been 16,222 deaths and 47,125 people have been hospitalized.

Read more here:

2 more local residents die of COVID-19 as new cases identified near The Villages - Villages-News

Covid-19 deaths will rise almost 80% by February, researchers foresee – CNN

The model, from the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine, forecasts there will most likely be about 389,087 deaths -- or 78% more fatalities -- by February 1.

The model's best-case scenario projects 314,000 deaths by then if all Americans use masks. There could be more than 477,000 deaths if mask mandates are eased, it projects.

The data show the pandemic increasing in younger populations -- and thus fewer deaths than a previous forecast. That model, released five days ago, projected about 395,000 deaths by February 1.

"We expect deaths to stop declining and begin increasing in the next one to two weeks," researchers with the institute said. "The winter surge appears to have begun somewhat later than the surge in Europe. Daily deaths will reach over 2,000 a day in January even with many states reimposing mandates before the end of the year."

21 states reach record 7-day average of new cases

As of Thursday, the nation is averaging 52,345 new cases a day, up 16% from the previous week, a trend that concerns health experts as we head into the cooler months.

"This is a very ominous sign. I think we're in for a pretty bad fall and winter," said Dr. Peter Hotez, professor and dean of tropical medicine at the Baylor College of Medicine.

"This is the time when we could be entering one of the worst periods of our epidemic and one of our worst periods in modern American public health," he said. "I'm very worried for the nation."

Thirty-five states are showing increases in new Covid-19 cases greater than 10% over the last week compared to the prior week. In seven states, cases are up less than 10%.

Only eight states -- Alabama, Delaware, Hawaii, Kentucky, Louisiana, Maine, Texas and Vermont -- are showing decreases in new cases compared to the previous week.

Since Sunday, 21 states have hit their peak 7-day average of new cases since the pandemic began, according to Johns Hopkins data, those being Alaska, Colorado, Idaho, Illinois, Indiana, Kansas, Kentucky, Minnesota, Missouri, Montana, Nebraska, New Mexico, North Dakota, Ohio, Oklahoma, Oregon, South Dakota, Utah, West Virginia, Wisconsin and Wyoming.

That kind of spread is "quite concerning," Dr. Anthony Fauci said Thursday on ABC's "Good Morning America."

"The issue is that as we enter, as we are now, in the cooler season of the fall, and ultimately the colder season of the winter, you don't want to be in that compromised position where your baseline daily infection is high and you are increasing as opposed to going in the other direction," Fauci said.

"We need to think about what we need to do as individuals," she said, "and how each of the decisions that we make can actually contribute to bringing this pandemic to an end."

Herd immunity is not the way out of pandemic, experts say

Wisconsin reported 3,747 new Covid-19 cases on Thursday -- a daily record, according to the state's Department of Health Services. That prompted Gov. Tony Evers to urge residents to help get the spread under control by staying home and wearing face coverings when out.

"The longer it takes for everyone to take this virus seriously, the longer it will take to get our economy and our communities back on track," Evers said at a news conference.

Arkansas, Illinois, Michigan, North Carolina and Ohio also reported their highest single-day totals on Thursday, though Michigan's data included a backlog of cases.

And Florida reported 3,356 cases on Thursday, the 11th day this month that the state Department of Health reported at least 2,200 new cases in a single day, according to CNN's tally.

Vaccine is the best weapon, expert says

Frieden was responding to recent efforts to promote herd immunity as an answer to Covid-19. The idea is being pushed by those eager to stop the economic damage the pandemic has caused.

White House senior administration officials, in a call with reporters Monday, discussed a controversial declaration written by scientists that advocates such an approach.

But the idea is "a dangerous fallacy unsupported by scientific evidence" that risks "significant morbidity and mortality across the whole population," 80 scientists from around the world wrote in an open letter.

"Any infection anywhere is potentially a threat somewhere else because even if you feel fine and get over it with no problems, no long-term consequences, you might spread it to someone who dies from it. And that's what we're seeing all over the country," Frieden said.

It is impossible to keep only the vulnerable protected from the spread, Frieden said. And letting the virus run rampant would likely lead to recurring epidemics because there is no evidence that people are protected long-term after they have been infected, according to the letter.

The best way to achieve widespread immunity, Frieden said, will be through a vaccine.

"The concept (of herd immunity) really comes from vaccines," Frieden said. "When you vaccinate enough people, the disease stops spreading, and that might be 60%, 80%, 90% for different diseases."

Frieden's comments were echoed Thursday by the WHO's Van Kerkhove, who said that allowing the virus to spread for the sake of herd immunity would lead to "unnecessary cases" and "unnecessary deaths."

"This is not a strategy for this virus," she said, "because there is so much that we can do."

CNN's Maggie Fox, Amanda Watts, Shelby Lin Erdman, Christina Maxouris Raja Razek, Lauren Mascarenhas, Jennifer Henderson, Rebekah Riess and Gisela Crespo contributed to this report.

Link:

Covid-19 deaths will rise almost 80% by February, researchers foresee - CNN

COVID-19 Daily Update 10-9-2020 – West Virginia Department of Health and Human Resources

TheWest Virginia Department of Health and Human Resources (DHHR) reports as of 10:00 a.m., October 9,2020, there have been 617,045 total confirmatorylaboratory results received for COVID-19, with 17,707 totalcases and 376 deaths.

DHHR has confirmed the deaths of a 74-yearold female from Kanawha County, a 64-year old male from Cabell County, a 70-yearold female from Logan County, a 65-year old male from Wayne County, a 68-yearold female from Jackson County, and a 61-year old female from Fayette County. Wecontinue to grieve the loss of more West Virginians today, said Bill J.Crouch, DHHR Cabinet Secretary. Our deepest sympathies are expressed to theirfamilies.

CASESPER COUNTY: Barbour(130), Berkeley (1,187), Boone (267), Braxton (16), Brooke (128), Cabell (978),Calhoun (29), Clay (48), Doddridge (40), Fayette (678), Gilmer (50), Grant(169), Greenbrier (142), Hampshire (115), Hancock (165), Hardy (98), Harrison(498), Jackson (311), Jefferson (470), Kanawha (3,054), Lewis (47), Lincoln(195), Logan (688), Marion (318), Marshall (196), Mason (154), McDowell (96),Mercer (450), Mineral (181), Mingo (427), Monongalia (2,135), Monroe (166),Morgan (73), Nicholas (136), Ohio (408), Pendleton (55), Pleasants (20),Pocahontas (60), Preston (168), Putnam (675), Raleigh (596), Randolph (303),Ritchie (18), Roane (65), Summers (62), Taylor (151), Tucker (44), Tyler (20),Upshur (168), Wayne (428), Webster (9), Wetzel (67), Wirt (19), Wood (401),Wyoming (135).

Please note that delaysmay be experienced with the reporting of information from the local healthdepartment to DHHR. As case surveillance continues at the local healthdepartment level, it may reveal that those tested in a certain county may notbe a resident of that county, or even the state as an individual in questionmay have crossed the state border to be tested.

Please visit the dashboard located at http://www.coronavirus.wv.gov for more information.

Free COVID-19 testing locations are available today in Mingo, Nicholas, Taylor, and Wood counties, and Saturday in Wood County:

Mingo County, October 9, 10:00AM 2:00 PM, Delbarton Volunteer Fire Department, County Highway 65/12, Delbarton,WV

Nicholas County, October9, 1:00 PM 4 PM, Nazarene Camp, 6461 Webster Road, Summersville, WV

Taylor County, October 9,12:00 PM 2:00 PM, First Baptist Church of Grafton, 2034 Webster Pike (US Rt.119 South), Grafton, WV

Wood County, October 9:10:00 AM 6:00 PM, South Parkersburg Baptist Church, 1655 Blizzard Drive, Parkersburg,WV

Wood County, October 10:9:00 AM 4:00 PM, South Parkersburg Baptist Church, 1655 Blizzard Drive, Parkersburg,WV

Testing is available to everyone,including asymptomatic individuals. For upcoming testing locations, pleasevisit https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

Go here to see the original:

COVID-19 Daily Update 10-9-2020 - West Virginia Department of Health and Human Resources

NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins – National Institutes of Health

News Release

Thursday, October 8, 2020

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun. The study is taking place in hospitalized adults with COVID-19 in the United States, Mexico and 16 other countries on five continents. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring and funding the Phase 3 trial, called Inpatient Treatment with Anti-Coronavirus Immunoglobulin, or ITAC.

The antibody solution being tested in the ITAC trial is anti-coronavirus hyperimmune intravenous immunoglobulin, or hIVIG. The antibodies in anti-coronavirus hIVIG come from the liquid portion of blood, or plasma, donated by healthy people who have recovered from COVID-19. These antibodies are highly purified and concentrated so that the anti-coronavirus hIVIG consistently contains several times more SARS-CoV-2 neutralizing antibodies than typically found in the plasma of people who have recovered from COVID-19.

The ITAC investigators hypothesize that giving people anti-coronavirus hIVIG at the onset of COVID-19 symptoms, before the body makes a protective immune response on its own, could augment the natural antibody response to SARS-CoV-2, thereby reducing the risk of more serious illness and death.

Finding safe and effective treatments for COVID-19 is absolutely critical, said NIAID Director Anthony S. Fauci, M.D. The ITAC trial will examine whether adding anti-coronavirus hIVIG to a remdesivir regimen can give the immune system a needed boost to suppress SARS-CoV-2 early in the course of illness, nipping the infection in the bud.

Leading the ITAC trial is Protocol Chair Mark Polizzotto, M.D., Ph.D., head of the Therapeutic and Vaccine Research Program at The Kirby Institute in the University of New South Wales, Sydney. The University of Minnesota is the coordinating center for the trial, which is being conducted by the NIAID-funded International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). While INSIGHT was established to conduct clinical studies on HIV, it also has been involved in clinical trials related to influenza-like illness and the role of anti-influenza hIVIG since 2009. The ITAC trial also is known as INSIGHT 013.

Four companies are collaborating to provide anti-coronavirus hIVIG for the trial: Emergent BioSolutions of Gaithersburg, Maryland; Grifols S.A. of Barcelona; CSL Behring of King of Prussia, Pennsylvania; and Takeda Pharmaceuticals of Tokyo. The hIVIG from Emergent BioSolutions and Grifols S.A. was developed with support from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. CSL Behring and Takeda Pharmaceuticals are providing anti-coronavirus hIVIG on behalf of a partnership of plasma companies called the CoVIg-19 Plasma Alliance.

Remdesivir is currently recommended for treating certain hospitalized patients with COVID-19, based on an analysis of available data from the NIAID-sponsored Adaptive COVID-19 Treatment Trial (ACTT). ACTT found that hospitalized patients with COVID-19 and lower respiratory tract involvement who received remdesivir had a statistically significant shorter time to recovery compared to patients who received placebo. Remdesivir is an investigational broad-spectrum antiviral discovered and developed by Gilead Sciences, Inc. of Foster City, California.

The ITAC study team will enroll 500 hospitalized adults ages 18 or older who provide informed consent, have had COVID-19 symptoms for 12 days or fewer, and do not have life-threatening organ dysfunction or organ failure. >Enrollment will occur at up to 58 sites in Africa, Asia, Europe, North America and South America. Study participants will be assigned at random to receive infusions of either anti-coronavirus hIVIG and remdesivir or a placebo and remdesivir. Neither the participants nor the study team will know who is receiving which treatment regimen.

hIVIG will be given as a single infusion of 400 milligrams (mg) per kilogram of current body weight. Remdesivir infusions will be administered as a 200-mg loading dose followed by a 100-mg once-daily intravenous maintenance dose during hospitalization for up to 10 days in total.

The main goal of the ITAC trial is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day seven. Health status will be based on an ordinal outcome with seven mutually exclusive categories ranging from no limiting symptoms due to COVID-19, to death. These categories capture the full range of severity experienced by hospitalized patients with COVID-19, according to the study investigators.

ITAC study participants will be followed for 28 days. If the trial goes to completion, the primary analysis will be completed after all participants finish 28 days of follow-up.

An independent data and safety monitoring board (DSMB) will review interim safety and efficacy data to ensure patient well-being and safety as well as study integrity.

The ITAC trial is associated with the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership. NIH and the Foundation for the NIH created ACTIV to develop a coordinated research strategy for prioritizing and speeding development of the most promising treatments and vaccines for COVID-19. ACTIV-associated trials are sponsored by NIH and have one or more industry partners. Both Gilead Sciences and Takeda Pharmaceuticals are ACTIV members.

Further information about the ITAC trial is available at ClinicalTrials.gov under study identifier NCT04546581.

NIAID conducts and supports researchat NIH, throughout the United States, and worldwideto study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Read more from the original source:

NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins - National Institutes of Health

Trumps COVID-19 experience doesnt prove anything – The Verge

President Donald Trump says hes recovered from COVID-19. Outside doctors say its too soon for him to return to public events, hes coughing on Fox News, and hes taking a potent steroid that can mask symptoms but Trump says hes not sick anymore. And hes crediting that recovery to an experimental drug made by the company Regeneron, which he said on Wednesday was a cure.

They gave me Regeneron, and it was, like, unbelievable. I felt good immediately, he said in a video recorded at the White House.

Theres no evidence that the Regeneron drug had anything to do with how good Trump did or did not feel. Theres hardly any data that the drug, which is a cocktail of artificial antibodies against the coronavirus, works at all. So far, all we have are a few bits of information on a small group of patients that were published in a press release. Trump was also given two other drugs, the antiviral remdesivir and the steroid dexamethasone. Theres no reason to believe the Regeneron drug which is actually named REGN-COV2; Regeneron is the name of the company that produces it was the thing responsible for how he said he felt. For a single patient, theres no way to tell for sure.

Antibody treatments could be a good way to treat COVID-19. The strategy is similar to convalescent plasma, which contains coronavirus antibodies generated by recovered patients. Instead of an unpredictable mixture of antibodies in blood, though, the drugs are concentrated cocktails of a few specific antibodies that seem to be particularly good at blocking the virus. Another pharmaceutical company, Eli Lilly, also has an antibody drug in development.

But neither drug has been tested thoroughly enough to say if it helps, hurts, or does nothing at all. Trumps wild claims about Regenerons candidate could make finding answers harder. Thats what happened last time he talked up a treatment strategy remember hydroxychloroquine? Trumps constant promotion of the anti-malarial drug, and the controversy around it, made people reluctant to enroll in clinical trials that were designed to figure out if it actually worked.

Trump also pressured federal agencies to quickly push out hydroxychloroquine. Experts worry that something similar could happen with Regenerons antibody therapy. Trump is already pushing the Food and Drug Administration to authorize it quickly. The circumstances of his treatment also could skew the clinical trial process: he got the drug under compassionate use, which makes untested and experimental products available to people who are seriously ill. Heralding it as a cure makes it seem as if we know more about it than we actually do, while simultaneously leaving the impression that VIPs like the president can skip the line, while the rest of us run the risk of getting a placebo in a clinical trial.

In reality, though, we still dont know if someone who gets the drug is better off than someone who gets a placebo. Thats what a trial is for. Hopefully, the drug works but anyone who claims to have answers right now is just making things up.

Heres what else happened this week.

Nearly One-Third of Covid-19 Patients in Study Had Altered Mental State

In one group of over 500 hospitalized COVID-19 patients, nearly a third had some kind of confusion or delirium. These sorts of mental problems show up in other viral infections, as well, and could be triggered by inflammation. (Pam Belluck / The New York Times)

The Coronavirus Unveiled

Researchers around the world are taking pictures and building models of the tiny, destructive virus. The images are helping them understand how it attacks cells and makes copies of itself. (Carl Zimmer / The New York Times)

COVID-19 Is Now the Third Leading Cause of Death in the U.S.

The virus is killing more people than stroke, Alzheimers, diabetes, kidney disease, and most other conditions that end up fatal. Right now, only heart disease and cancer are deadlier. (Youyou Zhou and Gary Stix / Scientific American)

FDA Releases Long-Awaited COVID-19 Vaccine Guidance

Pharmaceutical companies have to track vaccine clinical trial participants for at least two months before they ask the Food and Drug Administration to authorize their candidates, new guidelines from the agency say. This all but guarantees there wont be an approval by election day and could give people more confidence that the vaccines are being carefully evaluated. (Sydney Lupkin / NPR)

Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19

Like Regeneron, Eli Lilly published a press release showing that its antibody drug can keep some people with COVID-19 from needing to be hospitalized. But the benefits were small, and the data isnt published in a medical journal. (Matthew Herper / Stat News)

I Wont Be Used as a Guinea Pig for White People

In the US, Black people are more likely to be hospitalized with and die from COVID-19 than white people. Because of historic mistreatment by the medical community, though, theyre the least likely group to trust a vaccine and are reluctant to sign up for clinical trials. Community leaders are trying to encourage participation to ensure that the vaccines arent only tested on white people. (Jan Hoffman / The New York Times)

Hes fought COVID-19 for months. Can he ever really beat it?

Former Indiana State football player Larry Brown was on a ventilator for 50 days. Hes been in rehab for months. He doesnt know if hell ever be the same again. Right now, Im just trying to understand the new normal, Brown told the Associated Press. (Tom Murphy / Associated Press)

Only one of their children survived Sandy Hook. Now school posed a new threat: The virus.

Isaiah Marquez-Greenes sister was killed in the mass shooting at Sandy Hook Elementary in Newtown, Connecticut. He wasnt sure if his parents would be able to endure sending him back to his boarding school during a pandemic. (John Woodrow Cox / The Washington Post)

To the more than 36,933,166 people worldwide who have tested positive, may your road to recovery be smooth.

To the families and friends of the 1,068,995 people who have died worldwide 213,795 of those in the US your loved ones are not forgotten.

Stay safe, everyone

Read the original here:

Trumps COVID-19 experience doesnt prove anything - The Verge

COVID-19 Daily Update 10-8-2020 – West Virginia Department of Health and Human Resources

TheWest Virginia Department of Health and Human Resources (DHHR) reports as of 10:00 a.m., October 8,2020, there have been 609,111 total confirmatorylaboratory results received for COVID-19, with 17,325 totalcases and 370 deaths.

DHHR has confirmed the death of a 78-yearold male from Kanawha County. As many of us have growntired of COVID-19, it is more important than ever to stay vigilant in our preventionefforts, said Bill J. Crouch, DHHR Cabinet Secretary. Our sympathies are extendedto this gentlemans family.

CASESPER COUNTY: Barbour(118), Berkeley (1,161), Boone (263), Braxton (15), Brooke (125), Cabell (941),Calhoun (29), Clay (44), Doddridge (39), Fayette (670), Gilmer (50), Grant(165), Greenbrier (139), Hampshire (112), Hancock (160), Hardy (95), Harrison(486), Jackson (306), Jefferson (467), Kanawha (2,994), Lewis (43), Lincoln(193), Logan (679), Marion (312), Marshall (188), Mason (152), McDowell (96),Mercer (445), Mineral (180), Mingo (419), Monongalia (2,124), Monroe (157),Morgan (68), Nicholas (129), Ohio (396), Pendleton (54), Pleasants (20),Pocahontas (60), Preston (165), Putnam (658), Raleigh (581), Randolph (284),Ritchie (16), Roane (61), Summers (61), Taylor (151), Tucker (42), Tyler (18),Upshur (150), Wayne (425), Webster (9), Wetzel (67), Wirt (15), Wood (396),Wyoming (132).

Please note that delaysmay be experienced with the reporting of information from the local healthdepartment to DHHR. As case surveillance continues at the local healthdepartment level, it may reveal that those tested in a certain county may notbe a resident of that county, or even the state as an individual in questionmay have crossed the state border to be tested. Such is the case of Braxton and Tucker counties in thisreport.

Please visit the dashboard located at http://www.coronavirus.wv.gov for more information.

Free COVID-19 testing locations are available today in Boone, Cabell, Doddridge, Jackson, Kanawha, Lincoln, Marion, Summers,Taylor, and Upshur counties:

Boone County, October 8,1:00 PM 6:00 PM, Boone County Health Department, 213 Kenmore Drive, Danville,WV

Cabell County, October 8,9:00 AM 2:00 PM, Cabell County Health Department, 703 Seventh Avenue,Huntington, WV

Doddridge County, October 8, 12:00 PM 6:00 PM,Doddridge County Park, 1252 Snowbird Road, West Union, WV

Jackson County, October8, 2:00 PM 6:00 PM, ElderCare Parking Lot, 107 Miller Drive, Ripley, WV

Kanawha County, October8, 11:00 AM 6:00 PM, Schoenbaum Center, 1701 Fifth Avenue, Charleston, WV(flu shots offered)

Lincoln County, October8, 9:00 AM 2:00 PM, Lincoln County Health Department, 8008 Court Avenue,Hamlin, WV

Marion County, October 8,12:00 PM 3:00 PM, Marion County Health Department, 300 Second Street,Fairmont, WV

Summers County, October8, 1:00 PM 5:30 PM, Hinton Freight Depot, 506 Commercial Street, Hinton, WV

Taylor County, October 8,12:00 PM 2:00 PM, First Baptist Church of Grafton, 2034 Webster Pike (US Rt.119 South), Grafton, WV

Upshur County, October 8, 12:00 PM 6:00 PM,Buckhannon-Upshur High School, 270 BU Drive, Buckhannon, WV

Testing is available to everyone,including asymptomatic individuals. For upcoming testing locations, pleasevisit https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

See more here:

COVID-19 Daily Update 10-8-2020 - West Virginia Department of Health and Human Resources

COVID-19 Daily Update 10-7-2020 – West Virginia Department of Health and Human Resources

TheWest Virginia Department of Health and Human Resources (DHHR) reports as of 10:00 a.m., October 7,2020, there have been 602,802 total confirmatorylaboratory results received for COVID-19, with 17,139 totalcases and 369 deaths.

DHHR has confirmed the deaths of a 56-year old male from KanawhaCounty, a 65-year old male from Kanawha County, a 67-year old male from WyomingCounty, a 72-year old female from Harrison County, and an 81 year old male fromFayette County. It takes each of us doing our part to slow the spread of this disease,said Bill J. Crouch, DHHR Cabinet Secretary. Our sympathies are extended tothe families of these West Virginians.

CASESPER COUNTY: Barbour(116), Berkeley (1,148), Boone (262), Braxton (16), Brooke (124), Cabell (930),Calhoun (28), Clay (43), Doddridge (36), Fayette (664), Gilmer (49), Grant(163), Greenbrier (138), Hampshire (112), Hancock (160), Hardy (95), Harrison(473), Jackson (298), Jefferson (463), Kanawha (2,965), Lewis (42), Lincoln(191), Logan (673), Marion (311), Marshall (186), Mason (151), McDowell (96),Mercer (441), Mineral (179), Mingo (414), Monongalia (2,119), Monroe (155),Morgan (67), Nicholas (129), Ohio (392), Pendleton (54), Pleasants (20),Pocahontas (60), Preston (162), Putnam (647), Raleigh (571), Randolph (281),Ritchie (13), Roane (59), Summers (59), Taylor (150), Tucker (43), Tyler (17),Upshur (146), Wayne (425), Webster (9), Wetzel (65), Wirt (12), Wood (387),Wyoming (130).

Please note that delays may be experienced withthe reporting of information from the local health department to DHHR. As casesurveillance continues at the local health department level, it may reveal thatthose tested in a certain county may not be a resident of that county, or eventhe state as an individual in question may have crossed the state border to betested. Such is the case of Mercer and Waynecounties in this report.

Pleasevisit the dashboard located at http://www.coronavirus.wv.gov for more information.

Free COVID-19 testinglocations are available today in Berkeley,Harrison, Kanawha, Logan, Mason, Monongalia, Putnam, Taylor, Wayne, and Wyomingcounties:

Berkeley County, October7, 4:30 PM 7:30 PM, Mountain Ridge Middle School, 2771 Gerrardstown Road, Gerrardstown,WV

Harrison County, October7, 10:00 AM 3:00 PM, Robert C. Byrd High School, 1 Eagle Way, Clarksburg, WV

Kanawha County, October 7,3:00 PM 6:00 PM, Bible Center Church, 1 Bible Center Way, Charleston, WV (flushots offered)

Logan County, October 7, 10:00AM 2:00 PM, Old 84 Lumber Building, 100 Recovery Road, Peach Creek, WV

Mason County, October 7, 4:00PM 6:00 PM, Faith Baptist Church, 2550 2nd Street, Mason, WV

Monongalia County, October7, 9:00 AM 4:00 PM, West Virginia University, Student Recreation Center, 2001Rec Center Drive, Morgantown, WV

Putnam County, October 7,1:00 PM 5:00 PM, Poca Driving Range, 1 Dot Way, Poca, WV

Taylor County, October 7,12:00 PM 2:00 PM, First Baptist Church of Grafton, 2034 Webster Pike (US Rt.119 South), Grafton, WV

Wayne County, October 7, 9:00AM 1:00 PM, Wayne County Health Department, 217 Kenova Ave, Wayne, WV 25570

Wyoming County, October 7,8:30 AM 10:30 AM, Christian Fellowship Worship Center, 1877 Bear Hole Road, Pineville,WV

Testing is available to everyone, includingasymptomatic individuals. For upcoming testing locations, pleasevisit https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

Go here to read the rest:

COVID-19 Daily Update 10-7-2020 - West Virginia Department of Health and Human Resources

Governor Cuomo Announces New Record High Number of COVID-19 Tests Reported – ny.gov

Governor Andrew M. Cuomo today announced that 145,811 COVID-19 diagnostic test results were reported to New York State yesterdaya new record high. In the top 20 ZIP codes in areas that have seen recent outbreaks - Brooklyn, Queens, and Rockland and Orange Counties - 7,349 tests were conducted, yielding 426 positives or a 5.8 percent positivity rate. In the remainder of the state, 138,462 tests were conducted yielding 1,410 positives or a 1.01 percent positivity rate.

"Yesterday we did 145,000 tests, which is a new record for the State of New York. That's more tests than anyone's doing in the United States, a new high for us. The tests, and the reason we're increasing tests, is we're testing two universes--the normal statewide testing, which is what we've been doing, and then testing just in the hot spot ZIP codes," Governor Cuomo said. "Some have reported that the state's infection rate is going up. That is not a fact and that is incorrect. The clusters are what we are watching. The clusters are 6 percent of the state population. I don't think there's any other state that does enough testing to even know what 6 percent of the population is doing. So don't confuse 6 percent of the population and say it's representative of the state."

New York State continues to track clusters with a particular focus on areas where there are hot spot, cluster situations. Within the top 20 ZIP codes in counties with recent outbreaks - Brooklyn, Queens, and Rockland and Orange Counties - the average rate of positive tests is 5.8 percent. The rate of positive tests for the remainder of New York State, not counting these 20 ZIP codes, is 1.01 percent. These 20 ZIP codes contained 23.2 percent of all positive cases in New York State yesterday, but represent only 6.2 percent of the state's population.

Areas in hot spot communities, predominantly in Brooklyn, Queens and Rockland and Orange Counties, will continue to be subject of focused testing efforts including access to rapid testing machines. The ZIP codes are available below, sorted by highest positivity on 7-day average.

COUNTY

ZIP

% POSITIVE 10/7

% POSITIVE 10/6

% POSITIVE - 3 DAY AVG

% POSITIVE - 7 DAY AVG

% POSITIVE - 14 DAY AVG

Orange

10950

10.1%

13.3%

12.1%

15.0%

16.3%

Rockland

10952

16.0%

8.3%

14.4%

13.1%

14.1%

Rockland

10977

10.6%

10.1%

11.7%

11.7%

12.5%

Kings

11223

7.4%

5.3%

5.9%

7.6%

6.8%

Kings

11230

4.6%

4.8%

4.8%

6.1%

6.1%

Queens

11367

3.8%

5.8%

6.4%

6.0%

5.0%

Kings

11219

6.1%

10.6%

7.1%

5.9%

5.8%

Rockland

10901

4.6%

1.5%

4.5%

5.6%

6.4%

Kings

11204

4.2%

5.9%

5.3%

5.2%

5.4%

Kings

11210

3.2%

3.6%

4.4%

5.1%

5.4%

Orange

12550

4.2%

4.7%

4.0%

4.6%

3.4%

Kings

11229

3.8%

4.4%

4.0%

4.4%

4.2%

Rockland

See the original post here:

Governor Cuomo Announces New Record High Number of COVID-19 Tests Reported - ny.gov

VIRUS TRACKER – Oct. 10: 73 New COVID-19 Cases And 2 Deaths In Hawaii – Honolulu Civil Beat

Hawaii health officials reported the deaths of two more Oahu residents along with 73 new cases of COVID-19 on Saturday.

Fourteen new cases were reported on Hawaii island, and the rest of the cases were diagnosed on Oahu.

Gov. David Ige has given Hawaii County approval to make trans-Pacific passengers take a second COVID-19 test when they arrive on Hawaii island before letting them bypass the states 14-day quarantine. The second test will be administered at the airport and will be free for travelers, Hawaii News Now reports.

A new state inspection report found that required infection control procedures were not in place at the Yukio Okutsu State Veterans Home prior to the large COVID-19 outbreak at the facility. To date, 27 veterans and spouses have died at the home after being infected with the virus.

There are 137 people hospitalized with COVID-19 in the state, including 34 people in intensive care units. Hawaii hospital beds are 65% full and intensive care units are 59% full, including both COVID-19 patients and other patients.

The Department of Health has recorded 168 COVID-19 related deaths to date, but that does not include a number of deaths reported on Hawaii island. Civil Beat calculates 190 deaths so far, which includes 37 deaths in Hawaii County. Lags in state reporting are common as state health officials wait for information to verify COVID-19 fatalities.

The Life Care Center Hilo, a nursing home where 46 residents have tested positive for COVID-19, reported a third death from the virus Friday afternoon.

For more information, check this Hawaii Department of Health COVID-19 site or this state site, and the Hawaii Data Collaborative COVID-19 Tracking site.

13,371COVID-19 Cases

190Deaths

447,810Tests Performed

76Daily Case Count

3.3%Test Positivity

Want more information on COVID-19 in Hawaii? You can read all of Civil Beats coronavirus coverage, find answers to frequently asked questions or sign up for email newsletter updates all for free. And check out pictures of how community groups and volunteers have been helping out in our Community Scrapbook.

Sign Up

Sorry. That's an invalid e-mail.

Thanks! We'll send you a confirmation e-mail shortly.

See the original post:

VIRUS TRACKER - Oct. 10: 73 New COVID-19 Cases And 2 Deaths In Hawaii - Honolulu Civil Beat

As Election Day nears, COVID-19 spreads further into red America – Brookings Institution

While COVID-19s impact on the nations health and economy has been a continuing issue in the upcoming election, President Donald Trumps recent bout with the virus has made it personal for many Americans. Trumps health is likely to make the pandemic more relevant in parts of the country that voted for him in the 2016 presidential election.

This analysis extends my earlier tracking of COVID-19s spread into red states and counties across the country. It shows that while the overall rate of the spread has diminished somewhat from mid-summer, the disparity in cases between red and blue areas has continued, and is now widening in parts of the Midwest and in smaller communities. This may prove relevant to the presidential race, as some groups who live in these countiessuch as seniorsreport COVID-19 to be a top issue in the election, even eclipsing the economy.

The trajectory of new COVID-19 case rates (defined as the number of new monthly cases per 100,000 population) continues to grow in Americas red states. This pattern was first observed over the June-to-August period, and has now continued through September. (See Figure 1 for COVID-19 case rates across the nations red and blue states.)

In March, April, and May, blue states, as a group, exhibited higher COVID-19 case rates. But in June, they were overtaken by red states, and have remained lower since. The red state surge was especially high in July, rising to 746 cases per 100,000 residentsmore than double that of blue states. And while rates for both groups of states declined in August and September, the monthly rate of new COVID-19 cases in red states remains markedly higher. The September rate of 460 cases per 100,000 residents in red states is nearly twice that of blue states, and stands higher than even the peak blue state rate from April.

Individual states with the highest new COVID-19 rates have shifted as well, with many more red states dominating the list in recent months. These can be tracked in Figure 2, which displays individual red and blue states that showed monthly new COVID-19 rates exceeding 500 cases per 100,000 residents through September.

When the pandemic first hit the U.S., blue states in the Northeast exhibited the highest case rates. In April, both New York and New Jersey each registered new COVID-19 rates exceeding 1,100 cases per 100,000 population, followed by the New England states of Massachusetts, Connecticut, and Rhode Island, along with Washington, D.C. In May, Illinois and Maryland crossed the threshold of over 500 new cases per 100,000 populationas did Nebraska, the first red state to do so. No blue state reached the new case threshold in June, but one red state, Arizona, did.

July saw a surge of red states cross the new case rate threshold, with strong representation in the Southled by Florida with 1,400 cases per 100,000 residents, followed by Louisiana, Mississippi, South Carolina, and Alabama, along with western state Arizona. Each of these states exceeded 1,000 new cases per 100,000 residents. Eight additional red statessix in the Southshowed rates exceeding 500 new cases per 100,000 residents.

This surge continued into August, when 16 red states10 in the Southsaw high new COVID-19 case rates, led by Mississippi, Alabama, Georgia, Tennessee, and Florida. Further down the list were the midwestern states of North Dakota, South Dakota, Iowa, and Kansas, as well as the western state of Idaho. Although red states dominated the list of places with high rates of new COVID-19 cases in July and August, the blue states of California and Nevada also joined those ranks in both months.

September was noteworthy in that only red states reached the threshold of 500 new COVID-19 cases per 100,000 population. There was greater visibility in the Midwest, with North Dakota leading the 16 states in this group with a rate of 1,300 cases per 100,000 residents, followed by South Dakota and Wisconsin. Missouri, Kansas, and Nebraska are also on Septembers list, along with six southern and three western states. Although no blue states reached the new case rate threshold in September, those that come closest were the midwestern states of Illinois and Minnesota.

Just as new COVID-19 cases spread to red states, it is now occurring more broadly in red counties as well. This is significant because some may argueinaccuratelythat statewide surges in red states were only the result of high rates in heavily urban counties that are associated with Democratic voting patterns.

Figure 3 displays the trends in new monthly COVID-19 cases per 100,000 residents for red and blue counties (those won by either Donald Trump or Hillary Clinton in the 2016 election). Compared to the statewide analysis above, new COVID-19 rates were higher for blue counties though June. For July and August, new COVID-19 rates in red counties were only modestly higher than those in blue counties.

But in September, that difference widened. That month, red counties, as a group, registered a new COVID-19 case rate of 427 cases per 100,000 residents, compared to 315 for blue counties. Among individual states in September, it is noteworthy that this increase occurred in the swing states and near-swing states of Wisconsin, North Carolina, Ohio, Iowa, and Georgia.

Another recent shift in both red and blue states is the rise in new COVID-19 case rates in smaller metropolitan and non-metropolitan areas. As my previous report indicated, case rates in the early months of the pandemic tended to be highest in urban cores and suburbs surrounding large metropolitan areas. But over the summer, that pattern began to shift, with rising case rates in smaller-sized areas.

This was clearly the case in September. Figure 4 shows new COVID-19 cases per 100,000 persons for counties classified by a Brookings system that identifies urban cores, large suburbs, small metropolitan areas, and non-metropolitan areas. In both red and blue states, small metropolitan and non-metropolitan counties registered higher new COVID-19 case rates than urban cores or large suburban counties. This is especially the case in the electorally significant states of Pennsylvania, Michigan, Wisconsin, Iowa, and North Carolina.

This is important because in the 2016 election, the strongest Republican support came from rural or small-town residents. As the COVID-19 spreads into those areas, residents opinions on how the pandemic is being handled is likely to influence their vote.

In September, a total of 1,166 counties saw new COVID-19 cases exceed 500 per 100,000 residents. Fully 1,025 of them are red counties which Trump won in 2016, while only 141 favored Clinton. Those Trump counties are home to 41 million people, compared to 24 million residing in the Clinton counties.

A large portion of this group of red counties is located in the middle of the country, in states such as Missouri, Tennessee, Kansas, Texas, Oklahoma, Georgia, Iowa, North Dakota, South Dakota, and Wisconsin. Among all counties with high COVID-19 case rates in September, just five were located in urban core regions, with fully 1,038 (representing 38 million people) located in small metropolitan or non-metropolitan territory.

President Trumps contraction of COVID-19 has occurred just as the virus is spreading to new states and counties that he won in the 2016 election. The degree to which he will receive those residents continued support will likely depend on how they evaluate his administrations handling of the pandemic since it first started.

One group that the pandemic has heavily impacted is the older adult population. Older adults were strong Trump supporters in 2016, and they comprise an especially significant part of the electorate in rural and small towns where COVID-19 has begun to spread. A late September Washington Post/ABC poll showed that among persons age 65 and older, 24% said that the coronavirus outbreak was the single most important issue in selecting a president. It is likely that recent polls showing increased support for Joe Biden among this group could reflect a negative assessment of the presidents handling of the pandemic that now has hit closer to where they live.

The COVID-19 pandemic has caused unimaginable damage to large segments of the population. Its continued spread to more parts of the country is a matter that needs to be reckoned withand this Election Day, voters are poised to do exactly that.

Link:

As Election Day nears, COVID-19 spreads further into red America - Brookings Institution

COVID-19 UPDATE: Gov. Justice announces additional free testing at pharmacy drive-thrus; Mon County bars may reopen next Tuesday with restrictions -…

FRIDAYMAP UPDATEAdditionally Friday, Gov. Justice provided a look at West Virginias latest mid-week County Alert System map update, which featured an increase in the number of Orange an Gold counties across the state.

Redcounties: 0Orangecounties: 5 (Cabell, Doddridge, Harrison, Logan, Mingo)Goldcounties: 8 (Barbour, Berkeley, Boone, Jackson, Kanawha, Putnam, Randolph, Upshur)Yellowcounties: 3 (Morgan, Nicholas, Wirt)Greencounties: 39 (All others)

We have got to stay on our game in all of these counties all across our state, Gov. Justice said. If you'll look predominantly through the north and the central parts of our state, as well as the Eastern Panhandle, and even certain areas of the south, we have big areas of our state that are dadgum good. But we do have some problems. We know where they are and weve just got to everyone in those spots focused so we can slow down the spread.

The map is updated live on theDHHRs COVID-19 Dashboard(Click "County Alert System" tab)throughout the week for informational purposes and to provide an indication of how each county is trending ahead of each Saturday at 5 p.m.; the time when each county is assigned its official color designation for the next week, which determines the level of scholastic, athletic, and extracurricular activities permitted in each county for that particular week.

Read more from the original source:

COVID-19 UPDATE: Gov. Justice announces additional free testing at pharmacy drive-thrus; Mon County bars may reopen next Tuesday with restrictions -...

NIH RADx initiative advances six new COVID-19 testing technologies – National Institutes of Health

News Release

Tuesday, October 6, 2020

The National Institutes of Health, working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), today announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies. The six new Rapid Acceleration of Diagnostics (RADx) initiative contracts total $98.35 million for point-of-care and other novel test approaches that provide new modes of sample collection, processing and return of results. Innovations in these new technologies include integration with smart devices, mobile-lab processing that can be deployed to COVID-19 hot spots, and test results available within minutes.

These awards are part of the RADx Tech program, focused on rapidly advancing early testing technologies. RADx Tech and the RADx Advanced Technology Platforms (RADx-ATP) the latter for late-stage scale-up projects are now supporting a combined portfolio of 22 companies for a total of $476.4 million in manufacturing expansion contracts. These six additional technologies are expected to add as many as 500,000 tests per day to the U.S. capacity by the end of 2020 and 1 million tests per day by early 2021. Combined with previous contractsannounced in July and September, RADx Tech and RADx-ATP contracts are expected to increase test capacity by 2.7 million tests per day by the end of 2020.

Since launching in April, the NIH RADx initiative has moved swiftly to facilitate critical expansion of early and late-stage testing technologies as well as research to remove barriers to testing for underserved and vulnerable populations, said NIH Director Francis S. Collins, M.D., Ph.D. Each of the technologies emerging from the RADx initiative will play a critical role in extending accessibility to testing in diverse settings.

The latest group of testing technologies have been optimized and assessed within the NIH RADx Tech development pipeline and have met the rigorous criteria for advancement. Factors such as speed, accuracy, cost and accessibility are key considerations for RADx support. The RADx initiative provides financial support and expertise to help companies reach milestones for U.S. Food and Drug Administration authorization, scale-up and commercialization.

The current round of awards support five technologies that can be delivered to the point of care and a powerful laboratorytest, said Bruce J. Tromberg, Ph.D., director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and lead for RADx Tech, one of four programs of the NIH RADx initiative. The technologies include an antigen test that provides results in 15 minutes, a viral RNA test deployed in mobile vans that can travel to COVID hotspots and tests that require only saliva, nasal swabs or blood from a finger prick.

BARDA, part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, provided the funding for these RADx Tech contracts from emergency supplemental appropriations to the Public Health and Social Services Emergency Fund.

BARDA has contributed substantially to the nations COVID testing capacity with development support of 30 SARS-COV-2 diagnostic tests since March, 15 of which have achieved FDA emergency use authorization (EUA). Five of the 30 tests can distinguish between influenza and SARS-COV-2, the virus that causes COVID-19, from the same sample, and two of those have achieved EUA. To date, BARDAs industry partners have shipped more than 45 million tests to healthcare providers across the country.

Through the RADx initiative, we are expanding on our long-standing partnership with NIH to bring essential technology to the American people in the fight against COVID-19, said BARDA Acting Director Gary L. Disbrow, Ph.D.Our staff at BARDA is lending our expertise and experience in advanced development, manufacturing and scale up to help make as many accurate, fast tests available as we can as quickly as possible.

The following companies have achieved key RADx Tech milestones and will receive support for manufacturing and scale up:

Ellume USA LLC, Valencia, California

Two unique test cartridges contain a single-use, digital fluorescent immunoassay antigen test that returns accurate results in 15 minutes or less.One cartridge testing nasal swabs can be read out on two platforms by healthcare professionals, at the point of care or in laboratory settings for higher throughput. A second cartridge is being developed for home use with a self-administered nasal swab.

Luminostics, Inc., Milpitas, California

A rapid, smartphone-readout, antigen immunoassay that uses glow-in-the-dark nanomaterials to sensitively and specifically detect SARS-CoV-2 from shallow nasal swabs in 30 minutes or less, first for point-of-care use and later for home use.

Quanterix, Billerica, Massachusetts

A laboratory antigen test with ultra-sensitive single-molecule immunoassay technology to enable detection from a variety of sample types including nasopharyngeal, saliva or self-acquired blood from a finger prick. Sample collection, transport, and processing will occur within 24-48 hours using existing sample collection logistics infrastructure through a network of centralized labs.

Flambeau Diagnostics, Madison, Wisconsin

A lab module that can be deployed in a mobile van to screen asymptomatic individuals to detect SARS-CoV-2at low viral levelsin saliva samples, returning results in as little as one hour. The system can serve employers, schools and underserved populations. It uses newextractiontechnology to purify and concentrate viral RNA reliably and quickly.

Ubiquitome, Auckland, New Zealand

A battery-operated, mobile RT-PCR device that detects viral RNA with high accuracy in 40 minutes and reports results via its proprietary iPhone app. It offers high throughput and could be much lower cost than lab-based RT-PCR tests. The device is targeted for use in rural and metropolitan hospitals and mobile labs.

Visby Medical, San Jose, California

A palm-sized, single-use RT-PCR device that detects viral RNA with highly accurate results at the point of care in 30 minutes. The device was designed to be used by a person with minimal skills. This novel, versatile technology platform can also be adapted to provide simple, rapid tests for other diseases such as chlamydia, gonorrhea, and influenza.

About the Rapid Acceleration of Diagnostics (RADx SM) initiative: The RADx initiative was launched on April 29, 2020, to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. The initiative has four programs: RADx Tech, RADx Advanced Technology Platforms, RADx Underserved Populations and RADx Radical. It leverages the existing NIH Point-of-Care Technology Research Network. The RADx initiative partners with federal agencies, including the Office of the Assistant Secretary of Health, Department of Defense, the Biomedical Advanced Research and Development Authority, and U.S. Food and Drug Administration. Learn more about the RADx initiative and its programs:https://www.nih.gov/radx.

About HHS, ASPR, and BARDA: HHS works to enhance and protect the health and well-being of all Americans, providing for effective health and human services and fostering advances in medicine, public health, and social services. The mission of ASPR is to save lives and protect Americans from 21st century health security threats. Within ASPR, BARDA invests in the innovation, advanced research and development, acquisition, and manufacturing of medical countermeasures vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products needed to combat health security threats. To date, 55 BARDA-supported products have achieved FDA approval, licensure or clearance. For more on BARDAs portfolio for COVID-19 diagnostics, vaccines and treatments and about partnering with BARDA, visit medicalcountermeasures.gov. To learn more about federal support for the all-of-America COVID-19 response, visit coronavirus.gov.

About the National Institute of Biomedical Imaging and Bioengineering (NIBIB):NIBIBs mission is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website:https://www.nibib.nih.gov.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

The rest is here:

NIH RADx initiative advances six new COVID-19 testing technologies - National Institutes of Health

How Long Do You Need To Be Exposed To A COVID-19 Patient To Be At Risk? : Goats and Soda – NPR

Outdoor dining in Bonn, Germany. Indoor dining is riskier than outdoor meals, experts say. Outdoor air can disrupt viral particles that have been expelled. Andreas Rentz/Getty Images hide caption

Outdoor dining in Bonn, Germany. Indoor dining is riskier than outdoor meals, experts say. Outdoor air can disrupt viral particles that have been expelled.

Each week, we answer "frequently asked questions" about life during the coronavirus crisis. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject line: "Weekly Coronavirus Questions."

How long do you need to be exposed to someone with COVID-19 before you are at risk for being infected?

The question was brought to the forefront this week after the White House announced it would only perform contact tracing for people who had spent more than 15 minutes within 6 feet of President Trump, who tested positive for the coronavirus on Oct. 1. That "15-minute rule" is the Centers for Disease Control and Prevention's guideline for defining a close contact of an infected person.

But experts say the risk of infection is a lot more nuanced than that guidance might imply.

The 15-minute rule does not necessarily put you at zero risk if your exposure to an infected person was of a shorter duration. "It doesn't mean that you're getting off scot-free, nor does the '6-foot rule,' " says Dr. Joshua Barocas, an infectious disease specialist at Boston University School of Medicine.

"There is no magic number when it comes to distance or duration," says Emily Gurley, an epidemiologist and contact-tracing expert at the Johns Hopkins Bloomberg School of Public Health.

The coronavirus spreads when an infected person releases infectious particles while talking, coughing, singing, sneezing or even just breathing. Some of these particles are released as droplets, which generally fall to the ground within a few feet of the person who exhaled them. That's where the 6-foot guideline comes from though it's just a guideline, not a shield of impenetrability.

A person can also expel smaller infectious particles that linger in the air for minutes or even hours and travel farther than 6 feet in a room, Barocas notes. In a poorly ventilated, enclosed space, these smaller particles can build up in the air over time. If you're in a crowded room with lots of unmasked people talking, "whether you're [in contact for] 15 minutes or within 6 feet, it may not actually be that important anymore because there's so much virus in the air," Barocas says.

Gurley says in some jurisdictions, contact tracers also look for so-called proximate contacts people who were in an enclosed room with an infected person at greater than 6 feet away though they aren't considered close contacts under CDC guidance.

So where did that 15-minute part of the guideline come from? Gurley says it's based on earlier data from China on who was being infected and how infections occurred. "Even when they found lots and lots of very casual, quick contacts, that's not where they saw evidence of transmission," she says.

Instead, she says, infections were occurring when people had "meaningful" amounts of close contact such as traveling, dining or living together that had a higher probability of resulting in transmission. She says the 15-minute guideline is a way to help contact tracers quantify which types of interactions were long enough to be meaningful in this context.

But again, it's just a guideline, not a hard and fast rule. "We don't have strong evidence for exactly what the right distance or the right duration is, or else we'd use that," Gurley says.

And lots of variables can affect the risk of infection from close interactions, experts say.

"Certainly, if you're in very close contact with somebody who's shedding a lot of virus, and you happen to get a droplet on your hand and then wipe your nose, that could take far less than 15 minutes" to infect you, says Angela Rasmussen, a virologist at Columbia University Mailman School of Public Health.

How you interacted also matters a great deal, Barocas says. For example, was the infected person coughing? Was the person wearing a mask, which can help contain a lot of the infectious particles someone might be breathing out? Were you indoors or outdoors, where airflow would quickly disperse any infectious particles the person might have exhaled? How infectious was the person at the time of interaction? (Studies have shown that people with the coronavirus are most infectious just before and in the first few days after they start to show symptoms.) If an infected person were to cough on you while walking past, that would constitute a high-risk interaction even if it was brief, he says.

"All of those [factors] go into what I would think of as a combined likelihood or combined probability" of getting infected, Barocas says.

Conversely, not every type of lengthy interaction is equally risky, he says. Talking outdoors on the beach on a windy day for longer than 15 minutes with someone who is asymptomatic at the time is going to be less of a risk, he says.

While indoor settings are generally higher risk than outdoor ones, the context is key, Rasmussen says. An indoor bar where people are drinking, which requires unmasking, and possibly shouting to be heard over loud music (thus emitting more particles as they talk) is going to be riskier than a trip to a hair salon where everyone is masked and only a limited number of clients are in the room at the same time.

"I finally got my first pandemic haircut a couple of weeks ago," Rasmussen notes. "And I was there for two hours." But she wouldn't dine indoors, she says, because you can't eat while wearing a mask.

Rasmussen says because so many variables can influence the risk of transmission, it's important to focus on doing all the things we know can reduce the risk of infection wearing a mask, washing your hands, keeping your distance, trying to keep interactions outdoors as much as possible, avoiding crowds and poorly ventilated spaces. You might not always be able to do all of these things all of the time, she says but the more of them you can do at once, the more you'll reduce your risk of infection.

Read more:

How Long Do You Need To Be Exposed To A COVID-19 Patient To Be At Risk? : Goats and Soda - NPR

‘I shouldn’t be here’: Oshkosh bar owner in ICU with COVID-19 angry with Trump over out-of-control pandemic – Milwaukee Journal Sentinel

Since the coronavirus pandemic started, the United States has recorded more than 7.6 million cases of COVID-19 and 213,000 deaths. USA TODAY

Mark Schultz has been hit on both sides of this pandemic.

For six months it was his Oshkosh bar and restaurant, both of which are closed for now afterbeing hammered under state coronavirus restrictions.

Now it is Schultz himself, infected with COVID-19, lying in a hospital intensive care unit, laboring to breathe, unsure of when or whether he'll go home.

"I dont worry much about me, but I got a 10-year-old son and my fiance thats all I care about," he said through tears. "Myfamily is all at home. They are all worried about me. I dont want them to worry about me."

As he spoke by phone, he struggled with short breaths and was interruptedat timesby fits ofcoughs.

"I dont want them to go through this," he toldthe Milwaukee Journal Sentinel."Ihope I get to go home."

Schultz, 64, is the co-owner of Oblio's, a bar in Oshkosh that is beloved by a city that now has the highest rateof COVID-19 infection in the country, according to aNew York Times analysis.

At Oblio's, Schultz said he has three simple rules before people can belly up to the bar: Don't talk about politics. Don't talk about religion. And don't talk about someone's wife.

Now, as hereceives oxygen from a machine,Schultz says he has beenpushed to break thatfirst rule by President Donald Trump.

"I just want to punch him," Schultz said. "I always had to keep my politics to myself, but from where I'msitting now? Those days are over.

"Ishouldn'tbe here."

Trump, he said, should have been more upfront with the public from the beginning about the dangers of the coronavirus,should have acted quicker, promoted wearing face masks. If he had, Schultz believes, maybe the pandemicwould not have struck his community so hard, might not have wound up at his door.

Schultz says he started to feelsick last Friday, the same day the White House revealed Trump tested positive forCOVID-19.

On Monday, Trump told Americans"Don't be afraid of COVID."On Tuesday, Schultz checked into the hospital.

"Im just frustrated with the president the nonchalantnessof this virus," he said. "They should be afraid. It's nothing to mess with."

Schultz thinks it's likely he and his fiance, Sandy Ashenbrenner, caught the virus from his business partner. But he hopes, God willing, it hasn't been passed to his 10-year-old son, who hasn't received his test results yet.

"I couldnt breathe anymore," Schultz said about his decision to go to the hospital. "I couldnt breathe and I had a fever. I had aches and pains. I had headaches I never get headaches.

"Andthe tightness in my chest ..."

After arriving atthe hospital Tuesday,doctors told Schulzhe had developed double pneumonia, affecting both his lungs. He is now in anegative pressure ICU room receiving supplemental oxygen.

At times, Schultzlies on his stomach to help reduce his symptoms and blows into a machine to exercise his lungs. He tries to go without oxygen, but when he does, alarms attached to a blood oxygen monitor ring, then the tubes must go back into his nose.

He said he'sbarely slept in five days.

"I cough or I get the sweats and the chills," Schultz said Thursday. "I just get these hot flashes. I stay hot for hours, then last night when my oxygen thing went off, I couldnt get warm. I couldnt get enough covers on me."

Thursday was the worst night.

"I just can't sleep," he said Friday. "If you can't breathe, you can't sleep."

Schultz is on steroids, Tylenoland blood thinners.He said his oxygen has been more than doubled, and if he continues to need more, his doctor is going to try experimental treatment, including the Ebola drug Remdesivir and convalescent plasma therapy.

Schultz spoke to a Journal Sentinel reporter during what he called a "good spell coughinghard a few times but generally was able to chat.

"This lasts about an hour," he said. "Itcomes and goes and when it comes back, it hits you hard."

His blood oxygen level has at times dipped below 85% normal is at least 95% but generally, he's feeling the same, which he hopes, at least, is not bad news.

"Im just kind of floating along," Schultz said. "The doc says thats better than going the other way."

But Schultz is not sure he's going to leave the hospital. His voice shakes when he talks about his family being at home, worrying about him, but unable to see him.

Ashenbrenner, his fiance, has been battling COVID while their son attends school at home.

She said Friday she's feeling OKbut worried.

"My symptoms are nothing like what hes going through," she said. "Its very scary sometimes I talk to him and he seems a little better. Other times Im very worried hes not going to make it,"

Schultz isdocumenting his time in the hospital through a series of videos taken by phone and shared on YouTube. They're titled "Covid 19 ramblings of a pissed off Armenian."

The first begins with this message, aimed at Ashenbrenner:"Sandra Jean. I don't know if I'm going to make it."

He takes a few breaths.

"This s---- real. I want people to know that."

The videos are part diary and part therapy. Schulz airs his grievancesagainst the president and calls on viewers to support efforts to eliminate racial discrimination and the Black Lives Matter movement. Especially, he calls on them to take the threat of the virus seriously.

"Youve gotta wear masks. You'vegottasocial distance. You'vegotta wash your hands. You've gotta sanitize. You have to follow the rules. They're very simple."

Schultz's newfound activism does not appear partisan just angry.

In March, he hosted an event for Axios co-founder and Oshkosh native Jim VandeHei for a taped interview with Donald Trump Jr. but stayed in the back.

"I wouldn't have done it for anyone else," he said of VandeHei. "I don't like playing politics."

Schultz backs Democratic Gov. Tony Evers' mask mandate but doesn't agree with his orderto require restaurants and bars like his to limit customers to 25% of their capacity. Schultz said business at both his bar and restaurant is down 60%.

"These people do not have a concept of running a business," he said. "Its unbelievably hard right now. ...You'retrying to keep people employed and now I got two places that are closed.

"These people are out of work right now. Theyve got families."

Schultz said Evers' orders are suggesting to the public that the problem is with the service industry: "They put too much blame on bars or restaurants."

But Schultz also wants people to follow the safety rules put forward by Evers and public health experts.

"You've got to follow their guidelines," he said. "People have to feel comfortable going out. I dont blame anybody for not going out.

"I kind of commend it its being safe."

You can find out who your legislators are and how to contact them here.

Contact Molly Beckat molly.beck@jrn.com. Follow her on Twitter at @MollyBeck.

Read or Share this story: https://www.jsonline.com/story/news/politics/elections/2020/10/09/oshkosh-bar-owner-icu-coronavirus-blames-trump-crisis-covid-19-oblio/5936996002/

View original post here:

'I shouldn't be here': Oshkosh bar owner in ICU with COVID-19 angry with Trump over out-of-control pandemic - Milwaukee Journal Sentinel

Why COVID-19 is more deadly in people with obesityeven if they’re young – Science Magazine

Many very sick COVID-19 patients, like some in this Brazilian intensive care unit, have obesity.

By Meredith WadmanSep. 8, 2020 , 6:00 PM

Science's COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.

This spring, after days of flulike symptoms and fever, a man arrived at the emergency room at the University of Vermont Medical Center. He was youngin his late 30sand adored his wife and small children. And he had been healthy, logging endless hours running his own small business, except for one thing: He had severe obesity. Now, he had tested positive for COVID-19 and was increasingly short of breath.

He was admitted directly to the intensive care unit (ICU) and was on a ventilator within hours. Two weeks later, he died.

He was a young, healthy, hardworking guy, recalls MaryEllen Antkowiak, a pulmonary critical care physician who is medical director of the hospitals ICU. His major risk factor for getting this sick was obesity.

Since the pandemic began, dozens of studies have reported that many of the sickest COVID-19 patients have been people with obesity. In recent weeks, that link has come into sharper focus as large new population studies have cemented the association and demonstrated that even people who are merely overweight are at higher risk. For example, in the first metaanalysis of its kind, published on 26 August inObesity Reviews, an international team of researchers pooled data from scores of peer-reviewed papers capturing 399,000 patients. They found that people with obesity who contracted SARS-CoV-2 were 113% more likely than people of healthy weight to land in the hospital, 74% more likely to be admitted to an ICU, and 48% more likely to die.

A constellation of physiological and social factors drives those grim numbers. The biology of obesity includes impaired immunity, chronic inflammation, and blood thats prone to clot, all of which can worsen COVID-19. And because obesity is so stigmatized, people with obesity may avoid medical care.

We didnt understand early on what a major risk factor obesity was. Its not until more recently that weve realized the devastating impact of obesity, particularly in younger people, says Anne Dixon, a physician-scientist who studies obesity and lung disease at the University of Vermont. That may be one reason for the devastating impact of COVID-19 in the United States, where 40% of adults are obese.

People with obesity are more likely than normal-weight people to have other diseases that are independent risk factors for severe COVID-19, including heart disease, lung disease, and diabetes. They are also prone to metabolic syndrome, in which blood sugar levels, fat levels, or both are unhealthy and blood pressure may be high. A recent study from Tulane University of 287 hospitalized COVID-19 patients found that metabolic syndrome itself substantially increased the risks of ICU admission, ventilation, and death.

But on its own, BMI [body mass index] remains a strong independent risk factor for severe COVID-19, according to several studies that adjusted for age, sex, social class, diabetes, and heart conditions, says Naveed Sattar, an expert in cardiometabolic disease at the University of Glasgow. And it seems to be a linear line, straight up.

The impact extends to the 32% of people in the United States who are overweight. The largest descriptive study yet of hospitalized U.S. COVID-19 patients, posted as a preprint last month by Genentech researchers, found that 77% of nearly 17,000 patients hospitalized with COVID-19 were overweight (29%) or obese (48%). (The Centers for Disease Control and Prevention defines overweight as having a BMI of 25 to 29.9 kilograms per square meter, and obesity as a BMI of 30 or greater.)

Another study captured the rate of COVID-19 hospitalizations among more than 334,000 people in England. Published last month in theProceedings of the National Academy of Sciences, it found that although the rate peaked in people with a BMI of 35 or greater, it began to rise as soon as someone tipped into the overweight category. Many people dont realize they creep into that overweight category, says first author Mark Hamer, an exercise physiologist at University College London.

Among 334,000 people in England this spring, the chances of being hospitalized with COVID-19 increased steadily with their body mass index (BMI).

Hamer et al., PNAS, 10.1073/pnas.2011086117

The physical pathologies that render people with obesity vulnerable to severe COVID-19 begin with mechanics: Fat in the abdomen pushes up on the diaphragm, causing that large muscle, which lies below the chest cavity, to impinge on the lungs and restrict airflow. This reduced lung volume leads to collapse of airways in the lower lobes of the lungs, where more blood arrives for oxygenation than in the upper lobes. If you are already starting [with] this mismatch, you are going to get worse faster from COVID-19, Dixon says.

Other issues compound these mechanical problems. For starters, the blood of people with obesity has an increased tendency to clotan especially grave risk during an infection that, when severe, independently peppers the small vessels of the lungs with clots. In healthy people, the endothelial cells that line the blood vessels are normally saying to the surrounding blood: Dont clot, says Beverley Hunt, a physician-scientist whos an expert in blood clotting at Guys and St. Thomas hospitals in London. But we think that signaling is being changed by COVID, Hunt says, because the virus injures endothelial cells, which respond to the insult by activating the coagulation system.

Add obesity to the mix, and the clotting risk shoots up. In COVID-19 patients with obesity, Hunt says, Youve got such sticky blood, oh mythe stickiest blood I have ever seen in all my years of practice.

Immunity also weakens in people with obesity, in part because fat cells infiltrate the organs where immune cells are produced and stored, such as the spleen, bone marrow, and thymus, says Catherine Andersen, a nutritional scientist at Fairfield University. We are losing immune tissue in exchange for adipose tissue, making the immune system less effective in either protecting the body from pathogens or responding to a vaccine, she says.

The problem is not only fewer immune cells, but less effective ones, adds Melinda Beck, a co-author of theObesity Reviewsmetaanalysis who studies obesity and immunity at the University of North Carolina, Chapel Hill. Becks studies of how obese mice respond to the influenza virus demonstrated that key immune cells called T cells dont function as well in the obese state, she says. They make fewer molecules that help destroy virus-infected cells, and the corps of memory T-cells left behind after an infection, which is key to neutralizing future attacks by the same virus, is smaller than in healthy weight mice.

Becks work suggests the same thing happens in people: She found that people with obesity vaccinated against flu had twice the risk of catching it as vaccinated, healthy weight people. That means trials of vaccines for SARS-CoV-2 need to include people with obesity, she says, because coronavirus vaccines may be less effective in those people.

Beyond an impaired response to infections, people with obesity also suffer from chronic, low-grade inflammation. Fat cells secrete several inflammation-triggering chemical messengers called cytokines, and more come from immune cells called macrophages that sweep in to clean up dead and dying fat cells. Those effects may compound the runaway cytokine activity that characterizes severe COVID-19. You end up causing a lot of tissue damage, recruiting too many immune cells, destroying healthy bystander cells, says Ilhem Messaoudi, an immunologist who studies host responses to viral infection at the University of California, Irvine. Of the added risk from obesity, she adds: I would say a lot of it is immune-mediated.

The severity of COVID-19 in people with obesity helps explain the pandemics disproportionate toll in some groups. In American Indians and Alaska Natives, for example, poverty, lack of access to healthy food, lack of health insurance, and poor exercise opportunities combine to render rates of obesity remarkably high, says Spero Manson, a Pembina Chippewa who is a medical anthropologist at the University of Colorados School of Public Health. And obesity is connected to all these other [illnesses], such as diabetes and cardiovascular disease, rendering us susceptible to severe COVID-19, Manson says.

In addition, a large body of literature shows that people with obesity may delay seeking medical care due to fear of being stigmatized, increasing their likelihood of severe disease or death. Patients that experience weight stigma are less likely to seek care and less likely to seek follow up because they dont feel welcome in the health care environment, says Fatima Cody Stanford, an obesity medicine physician-scientist at Harvard Medical School and Massachusetts General Hospital.

COVID-19specific research on this question is urgently needed, she adds. We dont know how many people are dying in the community that are never making it in, Stanford says. Maybe that was [due] to their weight or to their race, the two most prevalent forms of stigma in the U.S.

For people with obesity, the extra risk adds a psychological burden, says Patty Nece, vice chair of the Obesity Action Coalition. My anxiety is just totally ramped up, she says, adding that because of stress eating shes recently regained 30 of the 100 pounds she lost before the pandemic. You have the general anxiety of this pandemic and then you layer on top of it: You in particular, you could get really sick.

Data on how to treat COVID-19 patients with obesity are scant. Published evidence supports giving such patients higher doses of anticoagulants, says Scott Kahan, an obesity medicine physician who directs the National Center for Weight and Wellness. But very little is known about whether and how to adjust other treatments such as remdesivir and dexamethasone, partly because patients with obesity are often excluded from clinical trials, he says. He urges that COVID-19 treatment trials include people with high BMIs wherever possible.

People with obesity should take extra care to avoid getting sick, Messaoudi says. If you are a person with obesity, be extra, extra cautious, she says. Wear your mask. Wash your hands. Avoid large gatherings.

In addition, exercising and, separately, losing even a little weight can improve the metabolic health of a person with obesity, and, in doing so, reduce their chances of developing severe COVID-19 if they become infected, says Stephen ORahilly, a physician-scientist who directs the MRC Metabolic Diseases Unit at the University of Cambridge. If youre 300 pounds, even losing a modest amount is likely to have a disproportionate benefit on how well you do with coronavirus infection. You dont have to become a slim Jim to benefit.

See more here:

Why COVID-19 is more deadly in people with obesityeven if they're young - Science Magazine

COVID-19 Daily Update 9-8-2020 – West Virginia Department of Health and Human Resources

TheWest Virginia Department of Health and Human Resources (DHHR) reports as of 10:00 a.m., on September 8,2020, there have been 462,547 total confirmatorylaboratory results received for COVID-19, with 11,661 totalcases and 250 deaths.

DHHR has confirmed the deaths of a63-year old female from Kanawha County, a 78-year old female from Putnam County,and an 85-year old female from Kanawha County. We mourn the tragic loss of these West Virginiansand send our deepest sympathies to their loved ones, said Bill J. Crouch, DHHRCabinet Secretary.

CASES PER COUNTY: Barbour(35), Berkeley (837), Boone (157), Braxton (9), Brooke (102), Cabell (595),Calhoun (19), Clay (29), Doddridge (13), Fayette (420), Gilmer (20), Grant(144), Greenbrier (106), Hampshire (93), Hancock (132), Hardy (76), Harrison(304), Jackson (219), Jefferson (394), Kanawha (1,737), Lewis (36), Lincoln (126),Logan (522), Marion (232), Marshall (134), Mason (123), McDowell (74), Mercer(350), Mineral (147), Mingo (282), Monongalia (1,433), Monroe (138), Morgan(41), Nicholas (58), Ohio (297), Pendleton (45), Pleasants (15), Pocahontas(45), Preston (142), Putnam (352), Raleigh (393), Randolph (228), Ritchie (6),Roane (37), Summers (21), Taylor (110), Tucker (12), Tyler (15), Upshur (50),Wayne (300), Webster (7), Wetzel (45), Wirt (8), Wood (324), Wyoming (72).

Pleasenote that delays may be experienced with the reporting of information from thelocal health department to DHHR. As case surveillance continues at the localhealth department level, it may reveal that those tested in a certain countymay not be a resident of that county, or even the state as an individual inquestion may have crossed the state border to be tested.Such is the case of Fayette Countyin this report.

Pleasevisit the dashboard located at http://www.coronavirus.wv.gov for more information.

Go here to see the original:

COVID-19 Daily Update 9-8-2020 - West Virginia Department of Health and Human Resources

Escape The Pandemic: Summer Camps Offer COVID-19-Free Bubbles This Fall – NPR

Camp Robin Hood in in Freedom, N.H., was one of the few around the country to offer a summer sleepover camp. This fall, it's offering a program where students can live and attend classes remotely. Jacob Spiers/Camp Robin Hood hide caption

Camp Robin Hood in in Freedom, N.H., was one of the few around the country to offer a summer sleepover camp. This fall, it's offering a program where students can live and attend classes remotely.

As millions of students return to virtual classes at their dining room tables, some parents who are also trying to work from home have decided to ship their kids off to camp.

This might seem crazy given reports that some sleepover camps that tried to open this summer turned in to coronavirus hot spots. At one camp in Georgia, hundreds of campers ended up getting infected with COVID-19. In fact, most sleepover camps in the U.S. didn't open at all due to concerns about spreading the virus among kids crammed into bunks and sharing communal toilets.

But some others that managed to successfully keep the virus at bay this summer are now offering a refuge from the virus to those who can afford it where students can live and attend classes remotely.

"Instead of working at their dining rooms at home, they're going to work at the dining room" at Camp Robin Hood, says Richard Woodstein, director of the camp, located in Freedom, N.H.

It's offering a five-week Semester at Camp starting Sept. 13. Campers will log in to their remote classes in the morning. "And once they're done with their work," he says, "we'll do camp stuff."

But this will all be done with strict COVID-19 protocols. Robin Hood and other camps that operated successfully over the summer used similar plans to deal with the virus. And Woodstein is confident they can do it again this fall.

In the days before anyone came to the camp, they had to get tested for the virus. Then the campers were tested again once they arrived.

"Every child at the front gate was given a nasal swab," Woodstein says. "We checked everyone's temperature in the cars. We won't let the parents get out of the cars."

The kids were divided up by bunks in to groups of 10. For the first week until everyone had passed a third COVID-19 test, campers from one bunk couldn't interact with kids from other bunks unless everyone was wearing masks.

Camp officials canceled all the usual field trips and excursions that they'd usually do outside of the 180-acre camp.

"Once we closed the drawbridge, nobody was allowed to leave," Woodstein says.

They hosted 300 kids this summer and there were no cases of COVID-19.

For the fall Semester at Camp, the plan is to create a similar bubble a world walled off from the pandemic.

But Woodstein cautions it wasn't easy. "We showed a lot of respect to the disease, a lot of respect to how quickly it could spread. But we just had a lot of processes in place. We washed our hands like crazy."

This fall, it's not just Robin Hood that's offering parents an alternative.

Camp North Star in Wisconsin is taking kids as young as 8 for a five-week fall session. A YMCA camp in North Carolina is renting out its cabins to kids and their parents, calling it a "solution for remote school and work."

So, are all of these just coronavirus disasters waiting to happen? A study published by the Centers for Disease Control and Prevention says no. Looking at more than 1,000 kids and staff who attended four camps this summer in Maine, the researchers found only three people tested positive for COVID-19 and the virus didn't spread.

Dr. Laura Blaisdell, the medical director at one of the camps and a lead author of the study, says there was no single magic bullet for keeping COVID-19 at bay.

"The magic bullet is the kitchen sink," Blaisdell says.

The key was to follow the science, she says, and put in place every public health measure they could "whether that's masking, physical distancing, testing, screening, temperature taking."

If anyone in a cabin came down with symptoms that might be COVID-19, the entire cabin was quarantined while the suspected case was tested for the virus.

But the quarantined campers still went on hikes and went swimming. They just didn't interact with the other bunks. Blaisdell says quarantine wasn't as bad as you might think.

"No, we didn't chain them to their bunk and throw them reams of meat," she says with a laugh.

As soon as the test results came back negative, the campers were released back into games of gaga ball and capture the flag.

Inside their sealed perimeters, these camps have shown that with enough testing and safety protocols they can create a world away from the virus. But the bubble comes at a price.

The fall session at Camp Robin Hood costs $9,000 for five weeks, which covers all expenses including COVID-19 testing.

Original post:

Escape The Pandemic: Summer Camps Offer COVID-19-Free Bubbles This Fall - NPR

Governor Cuomo Launches "The COVID-19 Report Card," An Online Dashboard Tracking Real-Time COVID-19 Infections and Testing Operations of…

Governor Cuomo Launches "The COVID-19 Report Card," An Online Dashboard Tracking Real-Time COVID-19 Infections and Testing Operations of Every New York School and School District | Governor Andrew M. Cuomo Skip to main content September 8, 2020

Albany, NY

Signs Executive Order to Ensure Schools, Local Health Departments, Labs, and All Testing Sites Properly Collect and Report COVID-19 Data on Daily Basis

COVID-19 Report Card Data Includes: Positive Cases by Date of Students and Staff; Number of Students and Staff On-Site; Percentage of On-Site Positive Cases; Number of Tests Administered by School, Test Type, Lab Used and Lag Time; Date of Last Submission and Update

Governor Andrew M. Cuomo today announced the launch of "The COVID-19 Report Card", an online dashboard which tracks real-time COVID-19 infections and testing operations of every New York school and school district. The Governor acted by Executive Order directing schools, local health departments, labs and all testing sites properly collect and report COVID-19 testing data for students and staff at each school in New York State, ensuring this information can be accurately presented on the online COVID-19 Report Card.

Audio Photos

As schools reopen and districts, local health departments, and labs begin reporting this data to the NYS Dept. of Health, the COVID-19 Report Card will be live at:https://schoolcovidreportcard.health.ny.gov/

"Facts empower people to make informed decisions for the health and safety of themselves and their families,"Governor Cuomo said."The COVID-19 Report Card will give parents, faculty and students the most up-to-date information on the status of their school and their school district's testing and results. I urge our school communities to stay vigilant and be smart."

The COVID-19 Report Card will give parents, faculty and students the most up-to-date information on the status of their school and their school district's testing and results.

The COVID-19 Report Cardwill provide parents, teachers, students and all New Yorkers with comprehensive data updated on a daily basis, including:

The COVID-19 Report Card online dashboard features user-friendly design to make it easy for parents, teachers, students and all New Yorkers to access the data in one central location. Visitors to the website can simply type in their home address to identify their school district, select their specific school, and find all reported positives, a breakdown of testing and results for students and teachers and the current enrollment. The dashboard will feature 7-day trend charts so visitors can track results over time.

The State of New York does not imply approval of the listed destinations, warrant the accuracy of any information set out in those destinations, or endorse any opinions expressed therein. External web sites operate at the direction of their respective owners who should be contacted directly with questions regarding the content of these sites.

Read the original post:

Governor Cuomo Launches "The COVID-19 Report Card," An Online Dashboard Tracking Real-Time COVID-19 Infections and Testing Operations of...

COVID-19 Daily Update 9-7-2020 – West Virginia Department of Health and Human Resources

TheWest Virginia Department of Health and Human Resources (DHHR) reportsas of 10:00 a.m., on September 7, 2020, there have been 461,558 total confirmatory laboratory results receivedfor COVID-19, with 11,575 total cases and 247 deaths.

DHHR has confirmed the death of an 86-year old female fromKanawha County. On this Labor Day, we must remember thoseWest Virginians who have lost their lives, said Bill J. Crouch, DHHR CabinetSecretary. We offer our deepest sympathies to all affected by COVID-19.

CASESPER COUNTY: Barbour (35), Berkeley (831), Boone(157), Braxton (9), Brooke (102), Cabell (589), Calhoun (18), Clay (29),Doddridge (13), Fayette (421), Gilmer (20), Grant (144), Greenbrier (106),Hampshire (93), Hancock (128), Hardy (76), Harrison (301), Jackson (217),Jefferson (389), Kanawha (1,731), Lewis (36), Lincoln (126), Logan (519),Marion (230), Marshall (134), Mason (120), McDowell (74), Mercer (350), Mineral(147), Mingo (280), Monongalia (1,401), Monroe (138), Morgan (41), Nicholas(57), Ohio (297), Pendleton (45), Pleasants (15), Pocahontas (45), Preston (141),Putnam (350), Raleigh (391), Randolph (228), Ritchie (6), Roane (37), Summers(21), Taylor (110), Tucker (12), Tyler (15), Upshur (46), Wayne (298), Webster(7), Wetzel (45), Wirt (8), Wood (324), Wyoming (72).

Pleasenote that delays may be experienced with the reporting of information from thelocal health department to DHHR. As case surveillance continues at the localhealth department level, it may reveal that those tested in a certain countymay not be a resident of that county, or even the state as an individual inquestion may have crossed the state border to be tested.Such is the case of LoganCounty in this report.

Pleasevisit the dashboard located at http://www.coronavirus.wv.gov for more information.

Read more:

COVID-19 Daily Update 9-7-2020 - West Virginia Department of Health and Human Resources